Healthcare Sector Stocks
The Healthcare sector has a total of 1063 stocks, with a combined market cap of $8.28 trillion, total revenue of $4.52 trillion and a weighted average PE ratio of 40.08.
Market Cap
8.28T
Revenue
4.52T
Profits
206.6B
PE Ratio
40.08
Profit Margin
4.57%
Dividend Yield
0.44%
1066 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 837.17B | -1.98% | 2,725,883 | 65.18B |
| 2 | JNJ | Johnson & Johnson | 585.39B | -0.44% | 6,878,187 | 94.19B |
| 3 | ABBV | AbbVie Inc. | 369.39B | -2.86% | 5,150,838 | 61.16B |
| 4 | AZN | AstraZeneca PLC | 314.50B | 1.37% | 2,049,269 | 58.74B |
| 5 | MRK | Merck & Co., Inc. | 298.84B | 0.02% | 6,387,255 | 65.01B |
| 6 | NVS | Novartis AG | 294.55B | -0.68% | 2,630,989 | 56.67B |
| 7 | UNH | UnitedHealth Group Incorporated | 251.66B | 1.20% | 6,406,507 | 447.57B |
| 8 | AMGN | Amgen Inc. | 187.56B | -1.51% | 1,603,438 | 36.75B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 182.57B | -0.62% | 1,696,260 | 44.56B |
| 10 | ABT | Abbott Laboratories | 179.16B | 0.48% | 5,445,896 | 44.33B |
| 11 | GILD | Gilead Sciences, Inc. | 173.41B | -0.42% | 4,921,040 | 29.44B |
| 12 | NVO | Novo Nordisk A/S | 163.33B | 1.37% | 14,695,158 | 48.59B |
| 13 | PFE | Pfizer Inc. | 161.09B | -0.81% | 30,924,907 | 62.58B |
| 14 | ISRG | Intuitive Surgical, Inc. | 160.56B | -2.67% | 1,646,823 | 10.06B |
| 15 | DHR | Danaher Corporation | 135.26B | 0.17% | 2,739,684 | 24.57B |
| 16 | SYK | Stryker Corporation | 126.88B | 0.65% | 1,485,879 | 25.12B |
| 17 | BMY | Bristol-Myers Squibb Company | 121.69B | -2.45% | 14,752,511 | 48.19B |
| 18 | SNY | Sanofi | 115.12B | 0.34% | 1,515,141 | 54.85B |
| 19 | GSK | GSK plc | 113.45B | 1.25% | 3,877,310 | 43.97B |
| 20 | VRTX | Vertex Pharmaceuticals Incorporated | 111.45B | -1.91% | 1,244,716 | 12.00B |
| 21 | MDT | Medtronic plc | 111.22B | 0.66% | 4,687,406 | 35.48B |
| 22 | MCK | McKesson Corporation | 108.31B | 1.37% | 570,336 | 397.96B |
| 23 | HCA | HCA Healthcare, Inc. | 105.49B | -0.61% | 905,217 | 75.60B |
| 24 | CVS | CVS Health Corporation | 93.49B | 1.38% | 6,034,400 | 399.83B |
| 25 | BSX | Boston Scientific Corporation | 93.36B | 1.32% | 13,895,350 | 20.07B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 78.18B | -1.98% | 999,271 | 14.34B |
| 27 | CI | The Cigna Group | 71.19B | 1.01% | 904,586 | 274.90B |
| 28 | ELV | Elevance Health, Inc. | 66.06B | 0.75% | 1,192,538 | 199.13B |
| 29 | COR | Cencora, Inc. | 63.18B | 2.25% | 1,266,154 | 325.78B |
| 30 | MDLN | Medline Inc. | 58.17B | 0.64% | 6,505,380 | 28.43B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 57.54B | -0.16% | 2,642,256 | 28.48B |
| 32 | CAH | Cardinal Health, Inc. | 50.37B | 0.96% | 1,503,740 | 244.67B |
| 33 | ZTS | Zoetis Inc. | 49.79B | 0.55% | 2,185,371 | 9.47B |
| 34 | EW | Edwards Lifesciences Corporation | 46.73B | -0.26% | 3,303,003 | 6.07B |
| 35 | ARGX | argenx SE | 46.37B | 0.49% | 371,962 | 4.24B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 45.35B | 0.87% | 734,217 | 4.30B |
| 37 | HLN | Haleon plc | 44.03B | -0.40% | 4,749,329 | 14.85B |
| 38 | BDX | Becton, Dickinson and Company | 44.00B | -1.17% | 2,368,101 | 21.92B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 42.29B | -3.01% | 872,386 | 3.71B |
| 40 | ALC | Alcon Inc. | 36.84B | -1.26% | 1,279,759 | 10.40B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 35.03B | -0.56% | 2,843,873 | 17.26B |
| 42 | INSM | Insmed Incorporated | 35.01B | -1.47% | 1,808,983 | 606.42M |
| 43 | ONC | BeOne Medicines AG | 34.46B | 0.76% | 133,246 | 5.34B |
| 44 | A | Agilent Technologies, Inc. | 32.63B | 0.82% | 1,111,902 | 7.07B |
| 45 | RMD | ResMed Inc. | 32.50B | 0.56% | 642,892 | 5.40B |
| 46 | GEHC | GE HealthCare Technologies Inc. | 32.10B | -2.22% | 2,750,408 | 20.63B |
| 47 | WAT | Waters Corporation | 29.85B | 1.45% | 727,267 | 3.17B |
| 48 | NTRA | Natera, Inc. | 29.48B | 2.35% | 1,279,465 | 2.31B |
| 49 | IQV | IQVIA Holdings Inc. | 29.08B | 0.50% | 794,277 | 16.31B |
| 50 | VEEV | Veeva Systems Inc. | 28.42B | 0.72% | 1,248,457 | 3.20B |
| 51 | RPRX | Royalty Pharma plc | 28.02B | 0.16% | 2,724,366 | 2.38B |
| 52 | BIIB | Biogen Inc. | 26.03B | -3.50% | 1,338,853 | 9.89B |
| 53 | PHG | Koninklijke Philips N.V. | 25.90B | -0.66% | 996,197 | 20.94B |
| 54 | MTD | Mettler-Toledo International Inc. | 25.51B | -1.11% | 87,734 | 4.03B |
| 55 | UTHR | United Therapeutics Corporation | 24.75B | -0.96% | 830,818 | 3.18B |
| 56 | DXCM | DexCom, Inc. | 23.95B | -0.24% | 2,407,058 | 4.66B |
| 57 | LH | Labcorp Holdings Inc. | 22.55B | 0.36% | 467,247 | 13.95B |
| 58 | BNTX | BioNTech SE | 21.88B | 1.97% | 785,603 | 3.37B |
| 59 | DGX | Quest Diagnostics Incorporated | 21.76B | 0.17% | 519,962 | 11.04B |
| 60 | STE | STERIS plc | 21.45B | -0.56% | 763,546 | 5.83B |
| 61 | HUM | Humana Inc. | 21.35B | 0.50% | 972,852 | 129.66B |
| 62 | ROIV | Roivant Sciences Ltd. | 20.28B | 1.76% | 4,995,623 | 13.31M |
| 63 | RVMD | Revolution Medicines, Inc. | 19.64B | 0.49% | 1,330,907 | - |
| 64 | MRNA | Moderna, Inc. | 19.51B | -1.66% | 4,629,854 | 1.94B |
| 65 | ILMN | Illumina, Inc. | 19.48B | 0.59% | 960,279 | 4.34B |
| 66 | INCY | Incyte Corporation | 19.09B | 1.73% | 1,157,618 | 5.14B |
| 67 | WST | West Pharmaceutical Services, Inc. | 18.35B | 0.82% | 795,051 | 3.07B |
| 68 | ZBH | Zimmer Biomet Holdings, Inc. | 17.78B | -0.15% | 2,164,750 | 8.23B |
| 69 | CNC | Centene Corporation | 17.27B | 3.42% | 4,832,028 | 176.15B |
| 70 | HOLX | Hologic, Inc. | 16.89B | 0.07% | 3,117,560 | 4.13B |
| 71 | GMAB | Genmab A/S | 16.77B | 1.03% | 1,081,615 | 3.72B |
| 72 | THC | Tenet Healthcare Corporation | 16.36B | -1.10% | 618,769 | 21.31B |
| 73 | VTRS | Viatris Inc. | 15.47B | -1.39% | 5,921,025 | 14.30B |
| 74 | RGC | Regencell Bioscience Holdings Limited | 15.23B | -8.66% | 329,088 | - |
| 75 | SMMT | Summit Therapeutics Inc. | 15.03B | 2.43% | 3,064,703 | - |
| 76 | PODD | Insulet Corporation | 14.38B | -1.32% | 882,679 | 2.71B |
| 77 | BBIO | BridgeBio Pharma, Inc. | 14.18B | -1.75% | 1,229,767 | 502.08M |
| 78 | MEDP | Medpace Holdings, Inc. | 14.14B | 1.81% | 284,308 | 2.53B |
| 79 | ASND | Ascendis Pharma A/S | 14.07B | 0.44% | 754,685 | 845.52M |
| 80 | COO | The Cooper Companies, Inc. | 13.69B | -1.76% | 2,049,423 | 4.15B |
| 81 | SNN | Smith & Nephew plc | 13.65B | 0.16% | 854,416 | 6.16B |
| 82 | NBIX | Neurocrine Biosciences, Inc. | 13.21B | -0.72% | 706,857 | 2.86B |
| 83 | PEN | Penumbra, Inc. | 12.96B | 0.43% | 747,863 | 1.40B |
| 84 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.55B | 3.22% | 344,995 | 958.40M |
| 85 | IONS | Ionis Pharmaceuticals, Inc. | 12.35B | -0.45% | 1,791,623 | 943.71M |
| 86 | GH | Guardant Health, Inc. | 12.31B | 2.94% | 1,743,916 | 982.02M |
| 87 | ALGN | Align Technology, Inc. | 12.16B | -1.23% | 1,081,409 | 4.03B |
| 88 | FMS | Fresenius Medical Care AG | 12.12B | 0.27% | 329,832 | 23.05B |
| 89 | GMED | Globus Medical, Inc. | 11.89B | 0.21% | 1,055,965 | 2.94B |
| 90 | JAZZ | Jazz Pharmaceuticals plc | 11.51B | -0.70% | 695,760 | 4.27B |
| 91 | ELAN | Elanco Animal Health Incorporated | 11.47B | -0.17% | 4,254,882 | 4.72B |
| 92 | EXEL | Exelixis, Inc. | 11.40B | -0.36% | 1,664,634 | 2.32B |
| 93 | ENSG | The Ensign Group, Inc. | 11.34B | -1.74% | 366,271 | 5.06B |
| 94 | SOLV | Solventum Corporation | 11.02B | -1.21% | 1,046,573 | 8.33B |
| 95 | RDY | Dr. Reddy's Laboratories Limited | 10.90B | -1.11% | 4,179,349 | 3.85B |
| 96 | UHS | Universal Health Services, Inc. | 10.79B | -0.70% | 547,003 | 17.36B |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 10.67B | -3.04% | 2,315,853 | 3.22B |
| 98 | RVTY | Revvity, Inc. | 9.94B | 1.16% | 949,752 | 2.86B |
| 99 | DVA | DaVita Inc. | 9.72B | -3.17% | 1,141,552 | 13.64B |
| 100 | EHC | Encompass Health Corporation | 9.68B | 0.01% | 804,114 | 5.94B |
| 101 | MASI | Masimo Corporation | 9.32B | 0.30% | 1,008,927 | 1.53B |
| 102 | ABVX | ABIVAX Société Anonyme | 9.27B | 2.96% | 962,854 | 5.37M |
| 103 | BTSG | BrightSpring Health Services, Inc. | 8.80B | 2.55% | 1,683,981 | 12.91B |
| 104 | ICLR | ICON Public Limited Company | 8.72B | 2.49% | 661,099 | 8.10B |
| 105 | PRAX | Praxis Precision Medicines, Inc. | 8.64B | -2.79% | 292,900 | 7.46M |
| 106 | AXSM | Axsome Therapeutics, Inc. | 8.62B | -1.91% | 616,848 | 638.50M |
| 107 | BAX | Baxter International Inc. | 8.61B | -0.60% | 6,513,196 | 11.24B |
| 108 | CRL | Charles River Laboratories International, Inc. | 8.56B | -0.58% | 839,180 | 4.02B |
| 109 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.55B | -3.00% | 1,445,790 | 1.09B |
| 110 | HSIC | Henry Schein, Inc. | 8.48B | 1.23% | 1,202,965 | 13.18B |
| 111 | TEM | Tempus AI, Inc. | 8.47B | 0.77% | 3,831,588 | 1.27B |
| 112 | QGEN | Qiagen N.V. | 8.46B | 1.61% | 1,276,363 | 2.09B |
| 113 | PCVX | Vaxcyte, Inc. | 8.40B | -0.21% | 1,014,323 | - |
| 114 | TECH | Bio-Techne Corporation | 8.31B | -0.65% | 1,802,099 | 1.22B |
| 115 | NUVL | Nuvalent, Inc. | 8.29B | -0.20% | 991,499 | - |
| 116 | CYTK | Cytokinetics, Incorporated | 8.22B | 0.18% | 2,479,271 | 88.04M |
| 117 | ATR | AptarGroup, Inc. | 8.04B | -0.58% | 297,467 | 3.78B |
| 118 | HALO | Halozyme Therapeutics, Inc. | 7.64B | -1.39% | 1,523,417 | 1.40B |
| 119 | KRYS | Krystal Biotech, Inc. | 7.63B | 0.79% | 203,764 | 389.13M |
| 120 | BIO | Bio-Rad Laboratories, Inc. | 7.56B | 0.59% | 253,681 | 2.58B |
| 121 | IBRX | ImmunityBio, Inc. | 7.54B | 2.24% | 14,195,695 | 113.29M |
| 122 | MOH | Molina Healthcare, Inc. | 7.26B | 2.62% | 1,283,650 | 43.56B |
| 123 | HQY | HealthEquity, Inc. | 7.15B | 1.50% | 640,139 | 1.31B |
| 124 | KYMR | Kymera Therapeutics, Inc. | 6.97B | 0.55% | 690,883 | 39.21M |
| 125 | ACLX | Arcellx, Inc. | 6.73B | 0.02% | 1,211,968 | 22.29M |
| 126 | BLTE | Belite Bio, Inc | 6.68B | 1.33% | 213,953 | - |
| 127 | RGEN | Repligen Corporation | 6.63B | -0.46% | 796,504 | 738.26M |
| 128 | PTGX | Protagonist Therapeutics, Inc. | 6.62B | 0.11% | 600,004 | 46.02M |
| 129 | GRFS | Grifols, S.A. | 6.61B | -0.12% | 758,790 | 8.83B |
| 130 | GKOS | Glaukos Corporation | 6.55B | 0.12% | 591,427 | 507.44M |
| 131 | APGE | Apogee Therapeutics, Inc. | 6.23B | 0.12% | 676,784 | - |
| 132 | CNTA | Centessa Pharmaceuticals plc | 6.14B | -0.43% | 3,646,709 | 15.00M |
| 133 | TERN | Terns Pharmaceuticals, Inc. | 6.08B | -0.13% | 10,851,345 | - |
| 134 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.89B | -2.08% | 546,140 | 189.76M |
| 135 | BLCO | Bausch + Lomb Corporation | 5.84B | -1.14% | 350,430 | 5.10B |
| 136 | ALKS | Alkermes plc | 5.79B | -0.60% | 2,484,801 | 1.48B |
| 137 | SRRK | Scholar Rock Holding Corporation | 5.75B | 1.34% | 2,025,235 | - |
| 138 | CGON | CG Oncology, Inc. | 5.70B | 1.03% | 1,278,710 | 4.04M |
| 139 | MIRM | Mirum Pharmaceuticals, Inc. | 5.68B | -0.48% | 742,702 | 521.31M |
| 140 | COGT | Cogent Biosciences, Inc. | 5.67B | -0.09% | 1,979,624 | - |
| 141 | PTCT | PTC Therapeutics, Inc. | 5.61B | -1.43% | 482,658 | 1.73B |
| 142 | BRKR | Bruker Corporation | 5.60B | 1.88% | 1,458,586 | 3.44B |
| 143 | ERAS | Erasca, Inc. | 5.54B | 7.29% | 5,480,026 | - |
| 144 | CAI | Caris Life Sciences, Inc. | 5.45B | 0.84% | 1,541,480 | 812.03M |
| 145 | CELC | Celcuity Inc. | 5.44B | -0.27% | 501,388 | - |
| 146 | XENE | Xenon Pharmaceuticals Inc. | 5.43B | 0.28% | 897,202 | 7.50M |
| 147 | AVTR | Avantor, Inc. | 5.34B | 1.67% | 5,095,117 | 6.55B |
| 148 | CHE | Chemed Corporation | 5.24B | 0.80% | 211,446 | 2.53B |
| 149 | TFX | Teleflex Incorporated | 5.21B | -0.52% | 493,485 | 1.99B |
| 150 | APLS | Apellis Pharmaceuticals, Inc. | 5.17B | 0.05% | 10,326,900 | 1.00B |
| 151 | PACS | PACS Group, Inc. | 5.05B | 1.48% | 586,954 | 5.29B |
| 152 | IMVT | Immunovant, Inc. | 4.99B | -2.39% | 2,024,993 | - |
| 153 | TGTX | TG Therapeutics, Inc. | 4.95B | -0.15% | 1,531,079 | 616.29M |
| 154 | LNTH | Lantheus Holdings, Inc. | 4.94B | 0.53% | 422,313 | 1.54B |
| 155 | CRSP | CRISPR Therapeutics AG | 4.75B | 1.43% | 1,727,476 | 3.51M |
| 156 | DNTH | Dianthus Therapeutics, Inc. | 4.55B | 1.70% | 879,699 | 2.04M |
| 157 | WAY | Waystar Holding Corp. | 4.55B | -0.13% | 1,595,255 | 1.10B |
| 158 | FOLD | Amicus Therapeutics, Inc. | 4.53B | - | 2,991,120 | 634.21M |
| 159 | CORT | Corcept Therapeutics Incorporated | 4.52B | 1.21% | 1,498,224 | 761.41M |
| 160 | HIMS | Hims & Hers Health, Inc. | 4.36B | -3.53% | 23,511,841 | 2.35B |
| 161 | OPCH | Option Care Health, Inc. | 4.30B | 3.70% | 1,865,306 | 5.65B |
| 162 | SHC | Sotera Health Company | 4.25B | 0.61% | 3,960,850 | 1.16B |
| 163 | RDNT | RadNet, Inc. | 4.25B | -0.94% | 997,872 | 2.04B |
| 164 | NVST | Envista Holdings Corporation | 4.23B | -0.35% | 1,695,234 | 2.72B |
| 165 | DOCS | Doximity, Inc. | 4.21B | -0.70% | 2,401,646 | 637.78M |
| 166 | MMSI | Merit Medical Systems, Inc. | 4.02B | -0.78% | 580,284 | 1.52B |
| 167 | VKTX | Viking Therapeutics, Inc. | 4.02B | 5.58% | 3,599,964 | - |
| 168 | AMRX | Amneal Pharmaceuticals, Inc. | 3.98B | -1.81% | 1,351,315 | 3.02B |
| 169 | LGND | Ligand Pharmaceuticals Incorporated | 3.98B | -0.02% | 221,911 | 268.09M |
| 170 | MMED | Minimed Group, Inc. | 3.93B | -3.25% | 724,636 | 2.89B |
| 171 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.90B | 1.80% | 1,247,681 | 7.70M |
| 172 | ALHC | Alignment Healthcare, Inc. | 3.83B | 5.10% | 2,728,165 | 3.95B |
| 173 | NAMS | NewAmsterdam Pharma Company N.V. | 3.79B | 0.55% | 725,189 | 22.50M |
| 174 | GPCR | Structure Therapeutics Inc. | 3.79B | 6.60% | 1,708,381 | - |
| 175 | ACAD | ACADIA Pharmaceuticals Inc. | 3.78B | -0.56% | 1,702,426 | 1.07B |
| 176 | IRTC | iRhythm Holdings, Inc. | 3.77B | -1.20% | 344,775 | 747.14M |
| 177 | STVN | Stevanato Group S.p.A. | 3.75B | -0.15% | 447,645 | 1.39B |
| 178 | SYRE | Spyre Therapeutics, Inc. | 3.74B | -2.70% | 438,009 | - |
| 179 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.74B | 1.43% | 436,333 | 677.56M |
| 180 | BLLN | BillionToOne, Inc. | 3.65B | -4.34% | 362,571 | 305.11M |
| 181 | EWTX | Edgewise Therapeutics, Inc. | 3.58B | 0.57% | 985,861 | - |
| 182 | OSCR | Oscar Health, Inc. | 3.55B | 1.62% | 4,372,000 | 11.70B |
| 183 | LEGN | Legend Biotech Corporation | 3.54B | 0.47% | 1,237,398 | 1.03B |
| 184 | LIVN | LivaNova PLC | 3.49B | -1.30% | 678,795 | 1.39B |
| 185 | TMDX | TransMedics Group, Inc. | 3.45B | 0.29% | 551,719 | 605.49M |
| 186 | LQDA | Liquidia Corporation | 3.32B | 0.56% | 786,248 | 158.32M |
| 187 | BKD | Brookdale Senior Living Inc. | 3.32B | 0.65% | 3,081,527 | 3.05B |
| 188 | DNLI | Denali Therapeutics Inc. | 3.27B | 4.93% | 1,625,741 | - |
| 189 | DYN | Dyne Therapeutics, Inc. | 3.11B | 4.09% | 1,939,505 | - |
| 190 | TNGX | Tango Therapeutics, Inc. | 3.09B | 1.93% | 2,923,246 | 62.38M |
| 191 | ICUI | ICU Medical, Inc. | 3.08B | -1.53% | 307,931 | 2.23B |
| 192 | TWST | Twist Bioscience Corporation | 3.08B | 1.35% | 970,546 | 391.56M |
| 193 | HNGE | Hinge Health, Inc. | 3.07B | 1.27% | 475,921 | 587.86M |
| 194 | TLX | Telix Pharmaceuticals Limited | 3.03B | -1.19% | 169,892 | 803.79M |
| 195 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.02B | -0.52% | 616,161 | 588.99M |
| 196 | ITGR | Integer Holdings Corporation | 2.99B | 0.47% | 329,798 | 1.85B |
| 197 | TARS | Tarsus Pharmaceuticals, Inc. | 2.98B | -0.14% | 370,831 | 451.36M |
| 198 | ALMS | Alumis Inc. | 2.97B | 2.82% | 1,412,363 | 24.05M |
| 199 | ARQT | Arcutis Biotherapeutics, Inc. | 2.93B | -1.95% | 1,090,531 | 376.07M |
| 200 | VERA | Vera Therapeutics, Inc. | 2.92B | 0.89% | 706,027 | - |
| 201 | SUPN | Supernus Pharmaceuticals, Inc. | 2.91B | -1.87% | 472,393 | 718.95M |
| 202 | RCUS | Arcus Biosciences, Inc. | 2.88B | 5.13% | 1,576,105 | 247.00M |
| 203 | IDYA | IDEAYA Biosciences, Inc. | 2.88B | 0.80% | 694,022 | 218.71M |
| 204 | TXG | 10x Genomics, Inc. | 2.85B | 1.27% | 1,277,544 | 642.82M |
| 205 | TVTX | Travere Therapeutics, Inc. | 2.81B | -3.12% | 1,147,835 | 490.73M |
| 206 | CON | Concentra Group Holdings Parent, Inc. | 2.68B | -1.60% | 539,000 | 2.16B |
| 207 | ORKA | Oruka Therapeutics, Inc. | 2.64B | 5.71% | 1,635,820 | - |
| 208 | HAE | Haemonetics Corporation | 2.64B | 1.05% | 426,368 | 1.32B |
| 209 | PRVA | Privia Health Group, Inc. | 2.62B | 0.66% | 723,251 | 2.12B |
| 210 | VCYT | Veracyte, Inc. | 2.56B | -0.46% | 702,899 | 517.15M |
| 211 | NHC | National HealthCare Corporation | 2.53B | 3.03% | 95,621 | 1.52B |
| 212 | KOD | Kodiak Sciences Inc. | 2.51B | -5.09% | 1,690,003 | - |
| 213 | HCM | HUTCHMED (China) Limited | 2.49B | 1.32% | 36,061 | 548.51M |
| 214 | IRON | Disc Medicine, Inc. | 2.49B | 0.62% | 570,029 | - |
| 215 | WRBY | Warby Parker Inc. | 2.48B | -5.23% | 2,367,640 | 871.91M |
| 216 | PBH | Prestige Consumer Healthcare Inc. | 2.48B | -9.02% | 1,594,938 | 1.10B |
| 217 | LMAT | LeMaitre Vascular, Inc. | 2.47B | -0.24% | 140,448 | 249.60M |
| 218 | IMNM | Immunome, Inc. | 2.47B | -2.72% | 1,602,338 | 6.94M |
| 219 | LFST | LifeStance Health Group, Inc. | 2.46B | -0.94% | 1,473,052 | 1.42B |
| 220 | BEAM | Beam Therapeutics Inc. | 2.45B | 1.82% | 1,853,344 | 139.74M |
| 221 | AAPG | Ascentage Pharma Group International | 2.44B | 3.96% | 6,548 | 82.08M |
| 222 | SRPT | Sarepta Therapeutics, Inc. | 2.44B | 4.97% | 3,157,106 | 2.20B |
| 223 | GRDN | Guardian Pharmacy Services, Inc. | 2.41B | 0.98% | 560,971 | 1.45B |
| 224 | MANE | Veradermics, Incorporated | 2.40B | 9.20% | 839,633 | - |
| 225 | ELVN | Enliven Therapeutics, Inc. | 2.32B | 2.75% | 810,852 | - |
| 226 | XRAY | DENTSPLY SIRONA Inc. | 2.32B | -0.26% | 2,455,809 | 3.68B |
| 227 | ZLAB | Zai Lab Limited | 2.30B | 0.34% | 707,426 | 460.16M |
| 228 | ADPT | Adaptive Biotechnologies Corporation | 2.28B | 2.63% | 1,565,135 | 276.98M |
| 229 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.26B | -3.84% | 7,824,517 | 874.84M |
| 230 | GRAL | GRAIL, Inc. | 2.26B | 2.59% | 792,247 | 147.17M |
| 231 | PAHC | Phibro Animal Health Corporation | 2.25B | 1.39% | 246,518 | 1.46B |
| 232 | RLAY | Relay Therapeutics, Inc. | 2.24B | 16.43% | 8,886,762 | 15.36M |
| 233 | MLYS | Mineralys Therapeutics, Inc. | 2.22B | 2.12% | 1,645,136 | - |
| 234 | SNDX | Syndax Pharmaceuticals, Inc. | 2.22B | 5.32% | 2,092,876 | 172.35M |
| 235 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | 0.14% | 1,403,638 | 158.18M |
| 236 | NKTR | Nektar Therapeutics | 2.21B | 1.69% | 552,798 | 55.23M |
| 237 | ACHC | Acadia Healthcare Company, Inc. | 2.21B | 1.23% | 2,976,646 | 3.31B |
| 238 | RARE | Ultragenyx Pharmaceutical Inc. | 2.20B | 4.81% | 1,770,395 | 673.00M |
| 239 | ADMA | ADMA Biologics, Inc. | 2.19B | 0.88% | 6,126,384 | 510.17M |
| 240 | TYRA | Tyra Biosciences, Inc. | 2.13B | 3.47% | 1,048,108 | - |
| 241 | HTFL | HeartFlow, Inc. | 2.13B | 1.35% | 1,818,095 | 176.03M |
| 242 | AUPH | Aurinia Pharmaceuticals Inc. | 2.08B | 0.90% | 1,259,953 | 283.06M |
| 243 | CLDX | Celldex Therapeutics, Inc. | 2.07B | -0.64% | 5,167,183 | 1.55M |
| 244 | AGIO | Agios Pharmaceuticals, Inc. | 2.06B | 2.95% | 1,425,392 | 54.03M |
| 245 | DFTX | Definium Therapeutics, Inc. | 2.06B | 0.39% | 1,957,745 | - |
| 246 | NEOG | Neogen Corporation | 2.05B | 0.21% | 2,292,430 | 880.32M |
| 247 | SLNO | Soleno Therapeutics, Inc. | 2.04B | 6.76% | 3,571,060 | 190.41M |
| 248 | SEM | Select Medical Holdings Corporation | 2.03B | 0.37% | 980,471 | 5.45B |
| 249 | BHC | Bausch Health Companies Inc. | 1.98B | -4.12% | 1,624,939 | 10.27B |
| 250 | GLPG | Galapagos NV | 1.95B | -1.14% | 176,232 | 1.31B |
| 251 | WGS | GeneDx Holdings Corp. | 1.94B | 1.04% | 338,519 | 427.54M |
| 252 | STOK | Stoke Therapeutics, Inc. | 1.94B | 2.34% | 564,255 | 184.42M |
| 253 | VRDN | Viridian Therapeutics, Inc. | 1.93B | -1.62% | 3,056,074 | 70.85M |
| 254 | AHG | Akso Health Group | 1.92B | -3.44% | 160,433 | 14.84M |
| 255 | ZYME | Zymeworks Inc. | 1.90B | -0.54% | 701,734 | 105.97M |
| 256 | MESO | Mesoblast Limited | 1.90B | -6.27% | 172,614 | 65.38M |
| 257 | PHVS | Pharvaris N.V. | 1.86B | -3.53% | 243,617 | - |
| 258 | OCUL | Ocular Therapeutix, Inc. | 1.85B | 1.92% | 4,372,204 | 51.95M |
| 259 | CAPR | Capricor Therapeutics, Inc. | 1.85B | 6.61% | 1,225,529 | 11.13M |
| 260 | SION | Sionna Therapeutics, Inc. | 1.82B | -1.96% | 525,211 | - |
| 261 | AXGN | Axogen, Inc. | 1.79B | 2.56% | 614,808 | 225.21M |
| 262 | PVLA | Palvella Therapeutics, Inc. | 1.77B | 2.56% | 333,943 | - |
| 263 | GENB | Generate Biomedicines, Inc. | 1.75B | 3.31% | 460,786 | 31.89M |
| 264 | VCEL | Vericel Corporation | 1.74B | 4.85% | 1,685,760 | 276.26M |
| 265 | MD | Pediatrix Medical Group, Inc. | 1.72B | 2.32% | 729,381 | 1.91B |
| 266 | ESTA | Establishment Labs Holdings Inc. | 1.71B | -0.56% | 279,442 | 211.08M |
| 267 | INVA | Innoviva, Inc. | 1.70B | -1.79% | 595,045 | 411.33M |
| 268 | ADUS | Addus HomeCare Corporation | 1.66B | -2.41% | 268,660 | 1.42B |
| 269 | ANAB | AnaptysBio, Inc. | 1.66B | 1.67% | 611,617 | 234.60M |
| 270 | OGN | Organon & Co. | 1.66B | 3.58% | 3,396,596 | 6.22B |
| 271 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.65B | 4.18% | 1,285,858 | -665.00K |
| 272 | RXRX | Recursion Pharmaceuticals, Inc. | 1.64B | 1.63% | 9,240,119 | 74.68M |
| 273 | ATEC | Alphatec Holdings, Inc. | 1.64B | -3.82% | 2,108,311 | 764.16M |
| 274 | AORT | Artivion, Inc. | 1.64B | 0.03% | 448,168 | 441.33M |
| 275 | AHCO | AdaptHealth Corp. | 1.64B | 1.43% | 1,056,935 | 3.24B |
| 276 | RAPP | Rapport Therapeutics, Inc. | 1.61B | 6.03% | 218,319 | - |
| 277 | HRMY | Harmony Biosciences Holdings, Inc. | 1.60B | -0.79% | 523,806 | 868.45M |
| 278 | NRIX | Nurix Therapeutics, Inc. | 1.60B | 0.19% | 1,165,288 | 83.98M |
| 279 | INSP | Inspire Medical Systems, Inc. | 1.58B | 2.52% | 1,001,549 | 911.98M |
| 280 | OCS | Oculis Holding AG | 1.58B | -1.74% | 109,784 | 1.51M |
| 281 | MBX | MBX Biosciences, Inc. | 1.57B | 2.17% | 601,665 | - |
| 282 | PLSE | Pulse Biosciences, Inc. | 1.56B | -0.13% | 143,502 | 350.00K |
| 283 | IMCR | Immunocore Holdings plc | 1.56B | 1.72% | 477,439 | 400.02M |
| 284 | SGRY | Surgery Partners, Inc. | 1.56B | -0.65% | 2,140,033 | 3.31B |
| 285 | OMCL | Omnicell, Inc. | 1.55B | 0.62% | 353,902 | 1.18B |
| 286 | NTLA | Intellia Therapeutics, Inc. | 1.55B | -1.06% | 2,742,329 | 67.67M |
| 287 | ANIP | ANI Pharmaceuticals, Inc. | 1.55B | -2.30% | 275,748 | 883.37M |
| 288 | NBTX | Nanobiotix S.A. | 1.53B | -8.89% | 98,529 | 38.27M |
| 289 | TRVI | Trevi Therapeutics, Inc. | 1.53B | 3.11% | 1,218,879 | - |
| 290 | DMRA | Damora Therapeutics, Inc. | 1.51B | 0.04% | 237,721 | - |
| 291 | NUVB | Nuvation Bio Inc. | 1.51B | -2.22% | 2,413,692 | 62.90M |
| 292 | SNDA | Sonida Senior Living, Inc. | 1.50B | 0.25% | 582,312 | 336.39M |
| 293 | PRGO | Perrigo Company plc | 1.49B | -1.36% | 3,146,717 | 4.25B |
| 294 | UFPT | UFP Technologies, Inc. | 1.48B | -1.02% | 207,611 | 602.80M |
| 295 | BHVN | Biohaven Ltd. | 1.47B | 1.87% | 2,600,006 | - |
| 296 | ARDX | Ardelyx, Inc. | 1.46B | -2.78% | 2,398,250 | 407.32M |
| 297 | ATRC | AtriCure, Inc. | 1.45B | 2.68% | 512,137 | 534.53M |
| 298 | VIR | Vir Biotechnology, Inc. | 1.45B | 0.44% | 1,727,183 | 68.56M |
| 299 | MAZE | Maze Therapeutics, Inc. | 1.43B | -1.17% | 780,214 | 2.50M |
| 300 | PRCT | PROCEPT BioRobotics Corporation | 1.42B | -0.95% | 797,730 | 308.05M |
| 301 | IOVA | Iovance Biotherapeutics, Inc. | 1.41B | -0.58% | 7,787,718 | 263.50M |
| 302 | SVRA | Savara Inc. | 1.41B | -0.36% | 811,618 | - |
| 303 | BCAX | Bicara Therapeutics Inc. | 1.41B | 4.73% | 919,280 | - |
| 304 | PGEN | Precigen, Inc. | 1.39B | 0.25% | 5,443,232 | 9.68M |
| 305 | IMTX | Immatics N.V. | 1.39B | 3.40% | 439,808 | 56.67M |
| 306 | AVAH | Aveanna Healthcare Holdings Inc. | 1.39B | 1.43% | 721,955 | 2.43B |
| 307 | ATAI | AtaiBeckley Inc. | 1.38B | 2.43% | 3,053,400 | 4.09M |
| 308 | WVE | Wave Life Sciences Ltd. | 1.37B | 6.59% | 4,068,293 | 42.73M |
| 309 | GLUE | Monte Rosa Therapeutics, Inc. | 1.37B | -0.47% | 1,240,310 | 123.67M |
| 310 | HROW | Harrow, Inc. | 1.31B | -0.34% | 344,221 | 272.30M |
| 311 | OLMA | Olema Pharmaceuticals, Inc. | 1.31B | -0.40% | 904,319 | - |
| 312 | PGNY | Progyny, Inc. | 1.30B | -1.54% | 1,155,317 | 1.29B |
| 313 | ENOV | Enovis Corporation | 1.30B | -3.12% | 609,074 | 2.25B |
| 314 | HCSG | Healthcare Services Group, Inc. | 1.29B | 2.80% | 671,494 | 1.84B |
| 315 | ZBIO | Zenas BioPharma, Inc. | 1.28B | 5.40% | 1,722,544 | 10.00M |
| 316 | TNDM | Tandem Diabetes Care, Inc. | 1.27B | -1.06% | 1,034,174 | 1.01B |
| 317 | TSHA | Taysha Gene Therapies, Inc. | 1.26B | 1.39% | 1,580,662 | 9.77M |
| 318 | NVAX | Novavax, Inc. | 1.25B | -3.99% | 4,650,901 | 1.12B |
| 319 | MLTX | MoonLake Immunotherapeutics | 1.25B | 5.08% | 1,686,296 | - |
| 320 | ASTH | Astrana Health, Inc. | 1.24B | 2.20% | 302,665 | 3.18B |
| 321 | ARDT | Ardent Health, Inc. | 1.24B | -0.12% | 300,493 | 6.32B |
| 322 | CRVS | Corvus Pharmaceuticals, Inc. | 1.23B | 1.80% | 660,469 | - |
| 323 | IRMD | IRADIMED CORPORATION | 1.23B | -0.32% | 79,046 | 83.81M |
| 324 | NVCR | NovoCure Limited | 1.20B | -2.68% | 1,152,038 | 655.35M |
| 325 | QDEL | QuidelOrtho Corporation | 1.17B | 4.04% | 1,178,294 | 2.73B |
| 326 | DBVT | DBV Technologies S.A. | 1.17B | 2.63% | 446,575 | 5.64M |
| 327 | KMTS | Kestra Medical Technologies, Ltd. | 1.16B | -1.05% | 388,016 | 83.72M |
| 328 | ALVO | Alvotech | 1.14B | 0.83% | 246,832 | 588.90M |
| 329 | NNNN | Anbio Biotechnology | 1.13B | 0.54% | 25,983 | 6.92M |
| 330 | PHAR | Pharming Group N.V. | 1.13B | -4.91% | 41,581 | 376.13M |
| 331 | SEPN | Septerna, Inc. | 1.13B | 3.32% | 287,816 | 45.95M |
| 332 | EYPT | EyePoint, Inc. | 1.12B | 2.92% | 1,154,737 | 31.37M |
| 333 | USPH | U.S. Physical Therapy, Inc. | 1.12B | -0.89% | 103,368 | 773.34M |
| 334 | AVBP | ArriVent BioPharma, Inc. | 1.10B | 2.77% | 362,884 | - |
| 335 | QURE | uniQure N.V. | 1.07B | 1.60% | 1,192,646 | 16.10M |
| 336 | CNMD | CONMED Corporation | 1.07B | -2.08% | 395,247 | 1.37B |
| 337 | ABCL | AbCellera Biologics Inc. | 1.07B | 0.28% | 3,489,508 | 75.13M |
| 338 | GERN | Geron Corporation | 1.06B | - | 33,580,702 | 183.88M |
| 339 | BFLY | Butterfly Network, Inc. | 1.05B | 0.49% | 3,686,273 | 97.61M |
| 340 | AZTA | Azenta, Inc. | 1.04B | 6.85% | 1,103,261 | 595.03M |
| 341 | XERS | Xeris Biopharma Holdings, Inc. | 1.04B | - | 1,337,692 | 291.85M |
| 342 | IVA | Inventiva S.A. | 1.04B | 0.74% | 321,489 | 9.31M |
| 343 | NEO | NeoGenomics, Inc. | 1.04B | 3.23% | 1,794,518 | 727.33M |
| 344 | PNTG | The Pennant Group, Inc. | 1.04B | -2.27% | 249,311 | 947.71M |
| 345 | INNV | InnovAge Holding Corp. | 1.03B | -5.11% | 276,585 | 915.37M |
| 346 | COLL | Collegium Pharmaceutical, Inc. | 1.03B | -2.83% | 583,674 | 780.57M |
| 347 | KALV | KalVista Pharmaceuticals, Inc. | 1.02B | 0.66% | 910,079 | 73.62M |
| 348 | STAA | STAAR Surgical Company | 1.00B | 4.55% | 961,412 | 239.44M |
| 349 | SSII | SS Innovations International, Inc. | 999.70M | 3.09% | 48,530 | 42.48M |
| 350 | CTMX | CytomX Therapeutics, Inc. | 985.77M | - | 4,718,172 | 76.20M |
| 351 | CMPX | Compass Therapeutics, Inc. | 981.48M | 0.37% | 3,183,387 | 850.00K |
| 352 | VOR | Vor Biopharma Inc. | 978.05M | 3.80% | 1,524,843 | - |
| 353 | AKTS | Aktis Oncology, Inc. | 960.14M | 1.76% | 384,686 | 6.50M |
| 354 | CRON | Cronos Group Inc. | 958.86M | 0.80% | 640,299 | 146.59M |
| 355 | BLFS | BioLife Solutions, Inc. | 942.33M | 1.14% | 209,434 | 96.21M |
| 356 | TDOC | Teladoc Health, Inc. | 940.15M | -0.19% | 3,494,674 | 2.53B |
| 357 | XNCR | Xencor, Inc. | 939.47M | 2.23% | 608,504 | 125.58M |
| 358 | CDNA | CareDx, Inc. | 937.77M | 2.46% | 341,855 | 379.81M |
| 359 | MPLT | MapLight Therapeutics, Inc. | 931.99M | 1.63% | 146,587 | - |
| 360 | INBX | Inhibrx Biosciences, Inc. | 927.98M | -5.25% | 190,000 | 1.30M |
| 361 | AMPH | Amphastar Pharmaceuticals, Inc. | 927.82M | 1.04% | 390,452 | 719.89M |
| 362 | EVO | Evotec SE | 921.82M | 1.97% | 88,684 | 887.40M |
| 363 | PCRX | Pacira BioSciences, Inc. | 919.12M | -0.39% | 749,187 | 726.41M |
| 364 | URGN | UroGen Pharma Ltd. | 916.20M | -0.63% | 381,800 | 109.79M |
| 365 | GHRS | GH Research PLC | 903.77M | -1.02% | 102,674 | - |
| 366 | JANX | Janux Therapeutics, Inc. | 902.74M | 2.27% | 1,304,860 | 10.00M |
| 367 | CLOV | Clover Health Investments, Corp. | 902.43M | 1.18% | 3,285,983 | 1.92B |
| 368 | LMRI | Lumexa Imaging Holdings, Inc. | 898.63M | -0.53% | 1,010,817 | 1.02B |
| 369 | PHAT | Phathom Pharmaceuticals, Inc. | 893.58M | 1.80% | 785,117 | 175.11M |
| 370 | ORIC | ORIC Pharmaceuticals, Inc. | 892.18M | 18.85% | 7,285,489 | - |
| 371 | FTRE | Fortrea Holdings Inc. | 883.58M | -0.79% | 845,294 | 2.72B |
| 372 | ANNX | Annexon, Inc. | 882.61M | 2.61% | 3,331,277 | - |
| 373 | ABUS | Arbutus Biopharma Corporation | 875.74M | -0.88% | 612,121 | 14.08M |
| 374 | INMD | InMode Ltd. | 873.72M | 0.66% | 661,724 | 370.50M |
| 375 | CGEM | Cullinan Therapeutics, Inc. | 873.39M | 3.52% | 1,149,537 | - |
| 376 | TALK | Talkspace, Inc. | 865.45M | 0.39% | 1,670,357 | 228.87M |
| 377 | OPK | OPKO Health, Inc. | 865.34M | 0.88% | 1,156,050 | 606.88M |
| 378 | CERT | Certara, Inc. | 860.95M | -1.64% | 6,252,430 | 418.84M |
| 379 | SDGR | Schrödinger, Inc. | 854.89M | 0.26% | 778,838 | 255.87M |
| 380 | EVMN | Evommune, Inc. | 854.36M | 5.80% | 380,635 | 13.00M |
| 381 | SANA | Sana Biotechnology, Inc. | 853.97M | 4.92% | 3,282,182 | - |
| 382 | TBPH | Theravance Biopharma, Inc. | 824.92M | 1.14% | 508,727 | 107.46M |
| 383 | SPRY | ARS Pharmaceuticals, Inc. | 824.17M | 2.34% | 1,274,391 | 84.28M |
| 384 | OMER | Omeros Corporation | 784.76M | -9.77% | 1,837,286 | - |
| 385 | BIOA | BioAge Labs, Inc. | 776.65M | -1.30% | 301,245 | 9.00M |
| 386 | MNKD | MannKind Corporation | 770.25M | -1.57% | 3,757,362 | 348.97M |
| 387 | JBIO | Jade Biosciences, Inc. | 763.91M | -3.31% | 402,826 | - |
| 388 | TLRY | Tilray Brands, Inc. | 763.12M | 6.68% | 5,709,383 | 858.28M |
| 389 | KURA | Kura Oncology, Inc. | 760.52M | 3.24% | 4,391,099 | 67.48M |
| 390 | MRVI | Maravai LifeSciences Holdings, Inc. | 758.35M | 2.79% | 1,751,526 | 185.74M |
| 391 | TENX | Tenax Therapeutics, Inc. | 755.26M | -6.16% | 333,708 | - |
| 392 | SGP | SpyGlass Pharma, Inc. | 748.31M | -8.10% | 130,657 | - |
| 393 | MGTX | MeiraGTx Holdings plc | 747.68M | 0.99% | 1,094,403 | 81.39M |
| 394 | CMPS | COMPASS Pathways plc | 746.47M | 3.02% | 1,310,919 | - |
| 395 | BVS | Bioventus Inc. | 745.90M | -1.97% | 318,107 | 568.09M |
| 396 | IART | Integra LifeSciences Holdings Corporation | 742.74M | -0.42% | 634,393 | 1.64B |
| 397 | SLS | SELLAS Life Sciences Group, Inc. | 741.68M | -1.90% | 4,862,807 | - |
| 398 | OMDA | Omada Health, Inc. | 741.28M | -0.24% | 1,035,969 | 260.21M |
| 399 | CSTL | Castle Biosciences, Inc. | 738.52M | -0.84% | 288,512 | 344.23M |
| 400 | SLDB | Solid Biosciences Inc. | 736.95M | 1.49% | 808,422 | - |
| 401 | RLMD | Relmada Therapeutics, Inc. | 733.18M | -1.55% | 1,844,566 | - |
| 402 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 713.09M | -1.33% | 164,842 | - |
| 403 | EHAB | Enhabit, Inc. | 710.13M | 0.21% | 1,005,413 | 1.06B |
| 404 | AMN | AMN Healthcare Services, Inc. | 703.54M | -1.94% | 951,851 | 2.73B |
| 405 | NUTX | Nutex Health Inc. | 703.25M | 2.52% | 172,496 | 875.26M |
| 406 | GDRX | GoodRx Holdings, Inc. | 702.28M | 1.99% | 1,004,923 | 796.85M |
| 407 | CBLL | CeriBell, Inc. | 699.00M | 0.27% | 217,754 | 89.06M |
| 408 | REPL | Replimune Group, Inc. | 694.44M | 10.51% | 3,182,698 | - |
| 409 | ARVN | Arvinas, Inc. | 693.98M | -4.24% | 1,289,307 | 262.60M |
| 410 | DSGN | Design Therapeutics, Inc. | 692.58M | 2.00% | 314,296 | - |
| 411 | ANRO | Alto Neuroscience, Inc. | 692.58M | -7.39% | 710,509 | - |
| 412 | DRUG | Bright Minds Biosciences Inc. | 689.00M | -0.36% | 188,443 | - |
| 413 | PSNL | Personalis, Inc. | 688.48M | 0.30% | 977,333 | 69.65M |
| 414 | ETON | Eton Pharmaceuticals, Inc. | 681.84M | -1.46% | 472,291 | 79.95M |
| 415 | LXRX | Lexicon Pharmaceuticals, Inc. | 673.65M | -3.05% | 2,315,942 | 49.80M |
| 416 | ESPR | Esperion Therapeutics, Inc. | 670.28M | - | 5,845,376 | 403.14M |
| 417 | GYRE | Gyre Therapeutics, Inc. | 650.16M | -1.52% | 63,440 | 116.59M |
| 418 | LBRX | LB Pharmaceuticals Inc | 649.93M | 3.55% | 342,089 | - |
| 419 | AVNS | Avanos Medical, Inc. | 648.78M | -0.99% | 334,444 | 701.20M |
| 420 | CBIO | Crescent Biopharma, Inc. | 644.35M | 0.41% | 209,004 | 10.84M |
| 421 | DRTS | Alpha Tau Medical Ltd. | 609.03M | - | 168,379 | - |
| 422 | OCGN | Ocugen, Inc. | 604.84M | - | 5,015,984 | 4.41M |
| 423 | ALLO | Allogene Therapeutics, Inc. | 604.57M | -3.13% | 4,328,903 | 22.00K |
| 424 | HSTM | HealthStream, Inc. | 600.34M | 0.25% | 164,871 | 304.06M |
| 425 | PRME | Prime Medicine, Inc. | 587.90M | -2.06% | 1,641,419 | 4.63M |
| 426 | ACRS | Aclaris Therapeutics, Inc. | 583.78M | 1.45% | 937,456 | 7.83M |
| 427 | MDXG | MiMedx Group, Inc. | 582.38M | -0.76% | 1,678,547 | 418.63M |
| 428 | CTKB | Cytek Biosciences, Inc. | 582.33M | 1.12% | 436,524 | 201.49M |
| 429 | SIBN | SI-BONE, Inc. | 579.45M | 0.85% | 672,866 | 200.93M |
| 430 | IRWD | Ironwood Pharmaceuticals, Inc. | 577.23M | -9.23% | 1,887,435 | 296.15M |
| 431 | PROK | ProKidney Corp. | 573.64M | 8.57% | 1,052,860 | 893.00K |
| 432 | TECX | Tectonic Therapeutic, Inc. | 573.06M | -0.84% | 163,002 | - |
| 433 | ZURA | Zura Bio Limited | 572.13M | - | 444,928 | - |
| 434 | TCMD | Tactile Systems Technology, Inc. | 559.66M | -5.28% | 173,067 | 329.52M |
| 435 | CRMD | CorMedix Inc. | 557.31M | 0.43% | 1,671,199 | 311.71M |
| 436 | ZVRA | Zevra Therapeutics, Inc. | 551.89M | -0.11% | 587,127 | 106.47M |
| 437 | VALN | Valneva SE | 543.61M | -2.71% | 248,378 | 205.07M |
| 438 | BWAY | BrainsWay Ltd. | 543.19M | -0.07% | 248,098 | 52.23M |
| 439 | KYTX | Kyverna Therapeutics, Inc. | 536.24M | 1.14% | 757,061 | - |
| 440 | FULC | Fulcrum Therapeutics, Inc. | 535.47M | 7.49% | 1,012,328 | 80.00M |
| 441 | EIKN | Eikon Therapeutics, Inc. | 534.44M | -1.79% | 252,604 | - |
| 442 | PRTA | Prothena Corporation plc | 530.79M | -1.69% | 848,132 | 9.68M |
| 443 | EMBC | Embecta Corp. | 524.10M | 0.68% | 1,084,183 | 1.08B |
| 444 | YDES | YD Bio Limited | 522.48M | 1.92% | 8,824 | 510.36K |
| 445 | AGMB | AgomAb Therapeutics NV | 522.46M | -9.00% | 185,408 | - |
| 446 | UPB | Upstream Bio, Inc. | 516.99M | 2.04% | 537,596 | 2.85M |
| 447 | VTVT | vTv Therapeutics Inc. | 510.90M | 1.58% | 40,992 | 17.00K |
| 448 | PHR | Phreesia, Inc. | 508.59M | -0.36% | 3,534,549 | 480.59M |
| 449 | RIGL | Rigel Pharmaceuticals, Inc. | 508.57M | 0.11% | 185,754 | 294.28M |
| 450 | AVR | Anteris Technologies Global Corp. | 507.04M | 3.38% | 527,705 | 1.91M |
| 451 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 5.42M |
| 452 | AQST | Aquestive Therapeutics, Inc. | 504.05M | - | 918,413 | 44.55M |
| 453 | CATX | Perspective Therapeutics, Inc. | 502.45M | -0.23% | 1,053,737 | 884.00K |
| 454 | CTNM | Contineum Therapeutics, Inc. | 501.80M | -0.07% | 103,435 | - |
| 455 | LRMR | Larimar Therapeutics, Inc. | 497.60M | 2.35% | 993,134 | - |
| 456 | VSTM | Verastem, Inc. | 494.51M | 1.44% | 1,837,540 | 30.91M |
| 457 | LYEL | Lyell Immunopharma, Inc. | 494.34M | 1.92% | 88,851 | 36.00K |
| 458 | NPCE | NeuroPace, Inc. | 493.22M | 4.12% | 170,411 | 99.99M |
| 459 | FLGT | Fulgent Genetics, Inc. | 485.17M | 2.31% | 556,224 | 322.67M |
| 460 | FDMT | 4D Molecular Therapeutics, Inc. | 483.97M | -3.95% | 706,895 | 85.21M |
| 461 | ADCT | ADC Therapeutics SA | 480.23M | -0.53% | 1,355,063 | 81.36M |
| 462 | KMDA | Kamada Ltd. | 475.22M | - | 32,296 | 180.46M |
| 463 | IMMX | Immix Biopharma, Inc. | 473.50M | 3.71% | 418,130 | - |
| 464 | TRDA | Entrada Therapeutics, Inc. | 473.40M | -2.45% | 178,007 | 25.42M |
| 465 | ABSI | Absci Corporation | 468.25M | -2.86% | 4,674,933 | 2.80M |
| 466 | OFIX | Orthofix Medical Inc. | 462.86M | -0.69% | 238,831 | 822.31M |
| 467 | ASMB | Assembly Biosciences, Inc. | 460.18M | -1.16% | 37,856 | 72.30M |
| 468 | STTK | Shattuck Labs, Inc. | 459.44M | 2.72% | 442,619 | 1.00M |
| 469 | AVIR | Atea Pharmaceuticals, Inc. | 458.91M | 1.95% | 442,794 | - |
| 470 | FBRX | Forte Biosciences, Inc. | 456.13M | 2.90% | 241,599 | - |
| 471 | ENGN | enGene Holdings Inc. | 448.16M | -1.04% | 332,758 | - |
| 472 | MYGN | Myriad Genetics, Inc. | 444.16M | 3.49% | 1,147,745 | 824.50M |
| 473 | BBNX | Beta Bionics, Inc. | 440.71M | -0.80% | 611,876 | 100.25M |
| 474 | RGNX | REGENXBIO Inc. | 440.26M | -1.16% | 420,546 | 170.44M |
| 475 | VREX | Varex Imaging Corporation | 440.15M | -1.13% | 152,708 | 854.40M |
| 476 | EPRX | Eupraxia Pharmaceuticals Inc. | 439.78M | -2.18% | 259,611 | - |
| 477 | ALT | Altimmune, Inc. | 434.55M | 7.05% | 2,737,031 | 41.00K |
| 478 | EBS | Emergent BioSolutions Inc. | 425.03M | -1.79% | 880,273 | 742.90M |
| 479 | ANGO | AngioDynamics, Inc. | 424.95M | -13.65% | 1,226,346 | 307.31M |
| 480 | LXEO | Lexeo Therapeutics, Inc. | 423.78M | 0.88% | 625,724 | - |
| 481 | AURA | Aura Biosciences, Inc. | 419.54M | -2.39% | 175,740 | - |
| 482 | AUNA | Auna S.A. | 418.91M | 0.71% | 100,569 | 1.30B |
| 483 | NAUT | Nautilus Biotechnology, Inc. | 418.30M | -1.49% | 217,138 | - |
| 484 | VNDA | Vanda Pharmaceuticals Inc. | 413.76M | -0.99% | 919,732 | 216.11M |
| 485 | KIDS | OrthoPediatrics Corp. | 405.98M | -1.41% | 114,207 | 236.35M |
| 486 | AVTX | Avalo Therapeutics, Inc. | 404.72M | 6.35% | 1,109,141 | 59.00K |
| 487 | PACB | Pacific Biosciences of California, Inc. | 404.68M | -0.74% | 6,489,347 | 160.01M |
| 488 | DNA | Ginkgo Bioworks Holdings, Inc. | 401.63M | 1.62% | 1,438,216 | 170.16M |
| 489 | CYH | Community Health Systems, Inc. | 396.24M | -0.34% | 835,449 | 12.49B |
| 490 | STRO | Sutro Biopharma, Inc. | 393.97M | -4.38% | 126,543 | 102.48M |
| 491 | XOMA | XOMA Royalty Corporation | 392.98M | -0.30% | 93,533 | 52.15M |
| 492 | LCTX | Lineage Cell Therapeutics, Inc. | 391.07M | -1.26% | 581,885 | 14.56M |
| 493 | NRC | National Research Corporation | 390.33M | -1.04% | 56,445 | 137.39M |
| 494 | WEAV | Weave Communications, Inc. | 386.16M | 3.59% | 1,232,548 | 239.02M |
| 495 | XFOR | X4 Pharmaceuticals, Inc. | 385.50M | -2.53% | 205,887 | 35.11M |
| 496 | RCKT | Rocket Pharmaceuticals, Inc. | 385.42M | -1.93% | 2,278,151 | - |
| 497 | CGC | Canopy Growth Corporation | 383.14M | 2.63% | 6,866,562 | 203.04M |
| 498 | IPSC | Century Therapeutics, Inc. | 382.81M | -2.74% | 678,110 | 109.16M |
| 499 | ENTA | Enanta Pharmaceuticals, Inc. | 381.31M | 1.31% | 112,823 | 66.98M |
| 500 | SIGA | SIGA Technologies, Inc. | 375.42M | 1.35% | 869,927 | 94.57M |